Blood test could replace invasive cancer tracking
NCT ID NCT00213798
Summary
This study investigated whether a simple blood test could monitor lung cancer progression without needing repeated tumor biopsies. Researchers followed 200 lung cancer patients to see if genetic markers in their blood matched their tumor's genetic changes. The goal was to develop a less invasive way to track how cancer responds to treatment over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Service de Chirurgie Thoracique, Hôpital Civil
Strasbourg, 67091, France
-
Service de Pneumologie, Hôpital Civil
Strasbourg, 67091, France
-
Service de Pneumologie, Hôpital Lyautey
Strasbourg, 67000, France
-
Service de Pneumologie, Hôpital de Hautepierre
Strasbourg, 67098, France
Conditions
Explore the condition pages connected to this study.